Back
Day Range
$24.46
$25.96
52-Week Range
$14.00
$30.68
Volume
249,171
50D / 200D Avg
$27.16
/
$21.03
Prev Close
$24.86
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -14.9 | 0.4 |
| P/B | 7.2 | 2.9 |
| ROE % | -70.1 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -62.51M
PEG of 0.60 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-70.09%
ROIC-29.89%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.01
Current Ratio5.96
Interest Coverage-99.49
Valuation
P/E Ratio
-14.88
P/B Ratio7.16
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100.00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -94.51M |
| ROE | -70.09% | ROA | -40.01% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -62.51M |
| ROIC | -29.89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 5.96 |
| Interest Coverage | -99.49 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -14.88 | P/B Ratio | 7.16 |
| P/S Ratio | N/A | PEG Ratio | 0.60 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.41B | Enterprise Value | 1.33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 686,000.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -94.51M | -85.78M | -88.80M | -38.70M | -18.55M |
| EPS (Diluted) | -1.81 | -2.12 | -2.97 | -1.18 | -0.57 |
| Gross Profit | 0.0 | -51.40M | 0.0 | 0.0 | 0.0 |
| Operating Income | -79.15M | -73.20M | -80.71M | -32.38M | -13.23M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 236.23M | 120.35M | 114.35M | 37.06M | 58.04M |
| Total Liabilities | 39.94M | 46.97M | 20.63M | 135.05M | 119.00M |
| Shareholders' Equity | 196.29M | 73.38M | 93.73M | -97.99M | -60.96M |
| Total Debt | 2.32M | 1.18M | 605,000.0 | 123.08M | 114.27M |
| Cash & Equivalents | 81.42M | 27.71M | 38.33M | 19.79M | 46.28M |
| Current Assets | 219.14M | 104.90M | 101.02M | 23.66M | 47.98M |
| Current Liabilities | 36.79M | 44.24M | 19.09M | 12.02M | 4.06M |